Point72 Asset Management
IMUX icon

Point72 Asset Management’s Immunic IMUX Stock Holding History

Point72 Asset Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-71,466
Closed -$1.06M – 2455
2023
Q1 		$1.06M Hold
71,466
– – ﹤0.01% 1096
2022
Q4 		$1M Sell
71,466
-61,034
-46% -$1.66M ﹤0.01% 1049
2022
Q3 		$4.19M Hold
132,500
– – 0.02% 770
2022
Q2 		$4.6M Buy
132,500
+60,000
+83% +$3.84M 0.02% 730
2022
Q1 		$8.19M Hold
72,500
– – 0.03% 569
2021
Q4 		$6.94M Buy
72,500
+10,000
+16% +$901K 0.03% 603
2021
Q3 		$5.53M Buy
+62,500
New +$6.15M 0.02% 640
2021
Q2 		– Sell
-43,305
Closed -$6.9M – 1062
2021
Q1 		$6.9M Buy
43,305
+22,855
+112% +$3.88M 0.03% 515
2020
Q4 		$3.13M Buy
+20,450
New +$3.67M 0.02% 662
2020
Q3 		– Sell
-17,500
Closed -$2.12M – 999
2020
Q2 		$2.12M Buy
+17,500
New +$1.78M 0.01% 582

Other funds holding IMUX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Point72 Asset Management's IMUX Position: Q2 2023 in Review

Point72 Asset Management sold out of Immunic (IMUX) in Q2 2023, closing a stake of 71,466 shares — an estimated $1.06M sold.

Point72 Asset Management first reported a position in IMUX in Q2 2020 and held it in 10 quarters. The position peaked at $8.19M in Q1 2022. 63 funds tracked by Wall St. Rank hold IMUX as of Q2 2023.

  • Point72 Asset Management reported no remaining Immunic position as of Q2 2023 after selling out during the quarter.
  • Point72 Asset Management sold 71,466 Immunic shares in Q2 2023, an estimated $1.06M.
  • Point72 Asset Management first reported a position in Immunic in Q2 2020 and held it in 10 quarters.
  • Point72 Asset Management's Immunic position peaked at $8.19M in Q1 2022.
  • 63 funds tracked by Wall St. Rank held Immunic as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.